Patents by Inventor Marc Pinard

Marc Pinard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7435540
    Abstract: The present invention features methods for identifying peptides that selectively bind to PrPSc or fragments thereof. The invention also features the use of such peptides in screening methods for the identification of candidate agents useful for the treatment of a prion disease.
    Type: Grant
    Filed: January 27, 2006
    Date of Patent: October 14, 2008
    Assignee: IDEXX Corporation
    Inventors: Neil Cashman, Eustache Paramithiotis, Sylvie La Boissière, Robert Lawton, Susan Francoeur, legal representative, Lisa Estey, Marc Pinard, Greg Francoeur
  • Publication number: 20060183156
    Abstract: The present invention features methods for identifying peptides that selectively bind to PrPSc or fragments thereof. The invention also features the use of such peptides in screening methods for the identification of candidate agents useful for the treatment of a prion disease.
    Type: Application
    Filed: January 27, 2006
    Publication date: August 17, 2006
    Inventors: Neil Cashman, Eustache Paramithiotis, Sylvie La Boissiere, Robert Lawton, Greg Francoeur, Susan Francoeur, Lisa Estey, Marc Pinard
  • Patent number: 7041807
    Abstract: In general, the invention features antibodies specific for PrPSc and diagnostic, therapeutic, and decontamination uses thereof. The invention also features synthetic peptides useful as immunogens for generating antibodies specific for PrPSc and therapeutic for the treatment of prion diseases.
    Type: Grant
    Filed: June 23, 2000
    Date of Patent: May 9, 2006
    Assignee: Caprion Pharmaceuticals, Inc.
    Inventors: Neil R. Cashman, Eustache Paramithiotis, Jacek Slon-Usakiewicz, Ashkan Haghighat, Marc Pinard, Trebor Lawton
  • Publication number: 20040072236
    Abstract: Peptides are disclosed which specifically bind to PrPSc. Methods of identifying these peptides by sequence-independent and/or sequence-dependent screening assays are also disclosed. Various applications of the method and of the peptides identified are described, including their use for identifying drugs for treating prion diseases.
    Type: Application
    Filed: September 27, 2002
    Publication date: April 15, 2004
    Inventors: Neil Cashman, Eustache Paramithiotis, Sylvie La Boissiere, Robert Lawton, Greg Francoeur, Susan Francoeur, Lisa Estey, Marc Pinard
  • Publication number: 20030114360
    Abstract: The use of a pharmaceutical composition comprising a peptide copolymer of lysine and tyrosine (e.g. copaxone) in combatting prion-related diseases is described.
    Type: Application
    Filed: December 10, 2002
    Publication date: June 19, 2003
    Inventors: Neil R. Cashman, Marc Pinard, Harry Ledebur